Alex Margolin
InvestorVenture Partner at Longwood Fund
About
Alexey (Alex) Margolin holds a Ph.D. and is a biotech entrepreneur, inventor, and scientist focused on rare and metabolic diseases. He cofounded four biotech companies—Alnara (acquired by Eli Lilly), Alcresta (acquired by Linden Partners), Allena (which went public), and Anagram Therapeutics—and has held CEO and Chairman roles. He earned undergraduate and Ph.D. degrees from Moscow University and completed postdoctoral training at MIT.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
AlcrestaAllenaAlnara
Investor
Anagram Therapeutics
Per the firm's website.
Colleagues at Longwood Fund
Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Arielle Jackson
Head, Corporate Communications & Industry Engagement at Longwood Fund
Barry Greene
Strategic Advisory Board at Longwood Fund
Frequently asked questions
- Who is Alex Margolin?
- Alexey (Alex) Margolin holds a Ph.D. and is a biotech entrepreneur, inventor, and scientist focused on rare and metabolic diseases. He cofounded four biotech companies—Alnara (acquired by Eli Lilly), Alcresta (acquired by Linden Partners), Allena (which went public), and Anagram Therapeutics—and has held CEO and Chairman roles. He earned undergraduate and Ph.D. degrees from Moscow University and completed postdoctoral training at MIT.
- Where does Alex Margolin work?
- Alex Margolin is Venture Partner at Longwood Fund.
- What does Alex Margolin invest in?
- Alex Margolin invests in Biotech.
- What boards does Alex Margolin sit on?
- Alex Margolin holds tracked board seats at Alcresta, Allena, Alnara.
- What companies has Alex Margolin invested in?
- Investments tracked here include Anagram Therapeutics.